Literature DB >> 33466857

Design, Synthesis, Molecular Docking, and Tumor Resistance Reversal Activity Evaluation of Matrine Derivative with Thiophene Structure.

Jinrui Wei1, Yuehui Liang2, Lichuan Wu3.   

Abstract

Nasopharyngeal carcinoma (NPC) frequently occurs in Southern China. The main treatments of NPC are chemotherapy and radiotherapy. However, chemo-resistance arises as a big obstacle in treating NPC. Therefore, there is a great need to develop new compounds that could reverse tumor drug resistance. In this study, eight matrine derivatives containing thiophene group were designed and synthesized. Structures of these 8 compounds were characterized by 1H-NMR, 13C-NMR, and high-resolution mass spectrometer (HRMS). The cytotoxicity and preliminary synergistic effects of these 8 compounds were detected against nasopharyngeal carcinoma (NPC) cells and cisplatin-resistant NPC cells (CNE2/CDDP), respectively. Furthermore, the in vivo and in vitro tumor resistance reversal effects of compound 3f were evaluated. Moreover, docking studies were performed in Bclw (2Y6W). The results displayed that compound 3f showed synergistic inhibitory effects with cisplatin against CNE2/CDDP cells proliferation via apoptosis induction. Docking results revealed that compound 3f may exert its effects via inhibiting anti-apoptosis protein Bcl-w.

Entities:  

Keywords:  drug resistance; matrine derivative; molecular docking; nasopharyngeal carcinoma

Mesh:

Substances:

Year:  2021        PMID: 33466857      PMCID: PMC7830115          DOI: 10.3390/molecules26020417

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  28 in total

1.  Effects of matrine on HepG2 cell proliferation and expression of tumor relevant proteins in vitro.

Authors:  Xue-Gong Qin; Zhang Hua; Wang Shuang; Yan-Hong Wang; Yu-Dong Cui
Journal:  Pharm Biol       Date:  2010-03       Impact factor: 3.503

2.  Design, synthesis and biological evaluation of 3,5-disubstituted 2-amino thiophene derivatives as a novel class of antitumor agents.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Carlota Lopez-Cara; Maria Kimatrai Salvador; Delia Preti; Mojgan Aghazadeh Tabrizi; Jan Balzarini; Peter Nussbaumer; Marcella Bassetto; Andrea Brancale; Xian-Hua Fu; Jun Li; Su-Zhan Zhang; Ernest Hamel; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  Bioorg Med Chem       Date:  2013-12-24       Impact factor: 3.641

Review 3.  Chemotherapy and chemo-resistance in nasopharyngeal carcinoma.

Authors:  Shuzhen Guan; Jinrui Wei; Lingkun Huang; Lichuan Wu
Journal:  Eur J Med Chem       Date:  2020-08-20       Impact factor: 6.514

Review 4.  BH3-only proteins in apoptosis and beyond: an overview.

Authors:  E Lomonosova; G Chinnadurai
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

5.  Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.

Authors:  Pierre Blanchard; Anne Lee; Sophie Marguet; Julie Leclercq; Wai Tong Ng; Jun Ma; Anthony T C Chan; Pei-Yu Huang; Ellen Benhamou; Guopei Zhu; Daniel T T Chua; Yong Chen; Hai-Qiang Mai; Dora L W Kwong; Shie Lee Cheah; James Moon; Yuk Tung; Kwan-Hwa Chi; George Fountzilas; Li Zhang; Edwin Pun Hui; Tai-Xiang Lu; Jean Bourhis; Jean Pierre Pignon
Journal:  Lancet Oncol       Date:  2015-05-06       Impact factor: 41.316

6.  Matrine derivative YF-18 inhibits lung cancer cell proliferation and migration through down-regulating Skp2.

Authors:  Lichuan Wu; Guizhen Wang; Jinrui Wei; Na Huang; Sen Zhang; Fangfang Yang; Ming Li; Guangbiao Zhou; Lisheng Wang
Journal:  Oncotarget       Date:  2017-02-14

Review 7.  Matrine: A Promising Natural Product With Various Pharmacological Activities.

Authors:  Hong Zhang; Linlin Chen; Xipeng Sun; Quanjun Yang; Lili Wan; Cheng Guo
Journal:  Front Pharmacol       Date:  2020-05-07       Impact factor: 5.810

8.  Molecular Mechanism of Matrine from Sophora alopecuroides in the Reversing Effect of Multi-Anticancer Drug Resistance in K562/ADR Cells.

Authors:  Zhi Chen; Nobuhiro Nishimura; Takayuki Okamoto; Koichiro Wada; Kohji Naora
Journal:  Biomed Res Int       Date:  2019-11-22       Impact factor: 3.411

9.  Toxicity and Antitumor Activity of a Thiophene-Acridine Hybrid.

Authors:  Thaís Lisboa; Daiana Silva; Sâmia Duarte; Rafael Ferreira; Camyla Andrade; Ana Luiza Lopes; Juliana Ribeiro; Davi Farias; Ricardo Moura; Malu Reis; Karina Medeiros; Hemerson Magalhães; Marianna Sobral
Journal:  Molecules       Date:  2019-12-24       Impact factor: 4.411

10.  Synergy between proteasome inhibitors and imatinib mesylate in chronic myeloid leukemia.

Authors:  Zheng Hu; Xiao-Fen Pan; Fu-Qun Wu; Li-Yuan Ma; Da-Peng Liu; Ying Liu; Ting-Ting Feng; Fan-Yi Meng; Xiao-Li Liu; Qian-Li Jiang; Xiao-Qin Chen; Jing-Lei Liu; Ping Liu; Zhu Chen; Sai-Juan Chen; Guang-Biao Zhou
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

View more
  1 in total

Review 1.  Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways.

Authors:  Chuansheng Yang; Zhikai Mai; Can Liu; Shuanghong Yin; Yantao Cai; Chenglai Xia
Journal:  Molecules       Date:  2022-05-30       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.